Literature DB >> 11865986

Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models.

J T Goorley1, W S Kiger, R G Zamenhof.   

Abstract

As clinical trials of Neutron Capture Therapy (NCT) are initiated in the U.S. and other countries, new treatment planning codes are being developed to calculate detailed dose distributions in patient-specific models. The thorough evaluation and comparison of treatment planning codes is a critical step toward the eventual standardization of dosimetry, which, in turn, is an essential element for the rational comparison of clinical results from different institutions. In this paper we report development of a reference suite of computational test problems for NCT dosimetry and discuss common issues encountered in these calculations to facilitate quantitative evaluations and comparisons of NCT treatment planning codes. Specifically, detailed depth-kerma rate curves were calculated using the Monte Carlo radiation transport code MCNP4B for four different representations of the modified Snyder head phantom, an analytic, multishell, ellipsoidal model, and voxel representations of this model with cubic voxel sizes of 16, 8, and 4 mm. Monoenergetic and monodirectional beams of 0.0253 eV, 1, 2, 10, 100, and 1000 keV neutrons, and 0.2, 0.5, 1, 2, 5, and 10 MeV photons were individually simulated to calculate kerma rates to a statistical uncertainty of <1% (1 std. dev.) in the center of the head model. In addition, a "generic" epithermal neutron beam with a broad neutron spectrum, similar to epithermal beams currently used or proposed for NCT clinical trials, was computed for all models. The thermal neutron, fast neutron, and photon kerma rates calculated with the 4 and 8 mm voxel models were within 2% and 4%, respectively, of those calculated for the analytical model. The 16 mm voxel model produced unacceptably large discrepancies for all dose components. The effects from different kerma data sets and tissue compositions were evaluated. Updating the kerma data from ICRU 46 to ICRU 63 data produced less than 2% difference in kerma rate profiles. The depth-dose profile data, Monte Carlo code input, kerma factors, and model construction files are available electronically to aid in verifying new and existing NCT treatment planning codes.

Entities:  

Mesh:

Year:  2002        PMID: 11865986     DOI: 10.1118/1.1428758

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  10 in total

Review 1.  Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors.

Authors:  N Gupta; R A Gahbauer; T E Blue; B Albertson
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

Review 2.  Computational dosimetry and treatment planning considerations for neutron capture therapy.

Authors:  David W Nigg
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

3.  Measurement of the (33)S(n,α) cross-section at n_TOF(CERN): Applications to BNCT.

Authors:  Marta Sabaté-Gilarte; Javier Praena; Ignacio Porras; José Manuel Quesada; Pierfrancesco Mastinu
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-16

Review 4.  Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT).

Authors:  Ryoichi Seki; Yushi Wakisaka; Nami Morimoto; Masaaki Takashina; Masahiko Koizumi; Hiroshi Toki; Mitsuhiro Fukuda
Journal:  Radiol Phys Technol       Date:  2017-11-20

5.  DNA Condensation with a Boron-Containing Cationic Peptide for Modeling Boron Neutron Capture Therapy.

Authors:  Chris C Perry; Jose Ramos-Méndez; Jamie R Milligan
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2019-10-10       Impact factor: 2.858

6.  RBE of thermal neutrons for induction of chromosome aberrations in human lymphocytes.

Authors:  E Schmid; F M Wagner; L Canella; H Romm; T E Schmid
Journal:  Radiat Environ Biophys       Date:  2012-12-23       Impact factor: 1.925

7.  Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons.

Authors:  Mitra Safavi-Naeini; Andrew Chacon; Susanna Guatelli; Daniel R Franklin; Keith Bambery; Marie-Claude Gregoire; Anatoly Rosenfeld
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

8.  10B Concentration, Phantom Size and Tumor Location Dependent Dose Enhancement and Neutron Spectra in Boron Neutron Capture Therapy.

Authors:  Gh Izadi Vasafi; M M Firoozabadi
Journal:  J Biomed Phys Eng       Date:  2019-12-01

9.  Thermal Neutron Relative Biological Effectiveness Factors for Boron Neutron Capture Therapy from In Vitro Irradiations.

Authors:  María Pedrosa-Rivera; Javier Praena; Ignacio Porras; Manuel P Sabariego; Ulli Köster; Michael Haertlein; V Trevor Forsyth; José C Ramírez; Clara Jover; Daniel Jimena; Juan L Osorio; Patricia Álvarez; Carmen Ruiz-Ruiz; María J Ruiz-Magaña
Journal:  Cells       Date:  2020-09-23       Impact factor: 6.600

10.  Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system.

Authors:  Naonori Hu; Hiroki Tanaka; Ryo Kakino; Syuushi Yoshikawa; Mamoru Miyao; Kazuhiko Akita; Kayako Isohashi; Teruhito Aihara; Keiji Nihei; Koji Ono
Journal:  Radiat Oncol       Date:  2021-12-24       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.